Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 1 art units • 1 examiners • 0 of 2 (0%) have an AI response strategy ready
Nanjing Leapsonics Technology Co. Ltd. operates in the Biotechnology & Pharmaceuticals technology area. The organization currently has 2 pending office actions. This workload is situated within 1 distinct art unit, suggesting a focused technical scope for the current filings. This concentration indicates a strategic emphasis on a particular technical niche within the Biotechnology & Pharmaceuticals sector. The company's patenting activity is currently limited to this specific area of development.
The prosecution involves 1 distinct examiner. SCHLIENTZ, LEAH H is the busiest examiner, handling 2 pending office actions. This alignment shows how the patent office has assigned the company's current applications. The use of 1 distinct examiner suggests a centralized review process where all communication is directed through this official. This structure simplifies the management of the portfolio but concentrates the prosecution risk.
For practitioners, the presence of 2 pending office actions in 1 distinct art unit means the prosecution path is very specific. Since SCHLIENTZ, LEAH H handles 2 pending office actions, the outcome depends on this individual's interpretation of the claims across all matters. This profile reflects an intellectual property strategy that relies on navigating the requirements and preferences of the assigned examiner.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SCHLIENTZ, LEAH H | 2 | 41.9% | +38.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17752104 | COMPOSITION FOR ULTRASOUND CONTRAST AGENT, ULTRASOUND CONTRAST AGENT AND PREPARATION METHOD THEREOF | SCHLIENTZ, LEAH H | 13d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17752104 | COMPOSITION FOR ULTRASOUND CONTRAST AGENT, ULTRASOUND CONTRAST AGENT AND PREPARATION METHOD THEREOF | SCHLIENTZ, LEAH H | 13d |
| 17741764 | COMPOSITION FOR MAGNETIC ULTRASOUND CONTRAST AGENT, MAGNETIC ULTRASOUND CONTRAST AGENT, MAGNETIC MICROBUBBLE ULTRASOUND CONTRAST AGENT AND PREPARATION METHOD THEREOF | SCHLIENTZ, LEAH H | — |
| Art Unit | Apps |
|---|---|
| 1618 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17752104 | COMPOSITION FOR ULTRASOUND CONTRAST AGENT, ULTRASOUND CONTRAST AGENT AND PREPARATION METHOD THEREOF | SCHLIENTZ, LEAH H | 1618 | §102§103 | Final Rejection | 13d | Pending | May 24, 2022 |
| 17741764 | COMPOSITION FOR MAGNETIC ULTRASOUND CONTRAST AGENT, MAGNETIC ULTRASOUND CONTRAST AGENT, MAGNETIC MICROBUBBLE ULTRASOUND CONTRAST AGENT AND PREPARATION METHOD THEREOF | SCHLIENTZ, LEAH H | 1618 | §103 | Final Rejection | — | Pending | May 11, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial